Diabetes drug gets mixed review
Diabetes drug gets mixed review
FDA panel links Avandia to health risks but majority recommends it stay on the market. Diabetes mellitus – Rosiglitazone – Health – Food and Drug Administration – Conditions and Diseases
Read more on Washington Post